A61K 31/711
Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine
Official title: Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
A61K31/711 (Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine) appears on 805 US grants and 1,661 published applications in this corpus.
Search patents in A61K- Granted patents
- 805
- Published applications
- 1,661
- Assignees
- 836
- Inventors
- 3,343
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 13 | 0 |
| 1998 | 11 | 0 |
| 1999 | 9 | 0 |
| 2000 | 12 | 0 |
| 2001 | 12 | 3 |
| 2002 | 12 | 24 |
| 2003 | 4 | 36 |
| 2004 | 14 | 41 |
| 2005 | 1 | 39 |
| 2006 | 10 | 27 |
| 2007 | 12 | 42 |
| 2008 | 10 | 58 |
| 2009 | 13 | 59 |
| 2010 | 21 | 47 |
| 2011 | 28 | 66 |
| 2012 | 27 | 37 |
| 2013 | 37 | 70 |
| 2014 | 57 | 77 |
| 2015 | 44 | 60 |
| 2016 | 41 | 49 |
| 2017 | 43 | 57 |
| 2018 | 38 | 79 |
| 2019 | 30 | 77 |
| 2020 | 53 | 94 |
| 2021 | 38 | 87 |
| 2022 | 47 | 110 |
| 2023 | 52 | 94 |
| 2024 | 33 | 81 |
| 2025 | 42 | 106 |
| 2026 | 38 | 141 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Assisted loading of hydrophobic molecules into liposomes6 Oct 2026US 12,751,922 B2University of Connecticut
- Long-acting low-toxicity novel cationic lipid compounds and composition thereof29 Sep 2026US 12,746,208 B2Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
- Stealth lipid nanoparticle compositions for cell targeting29 Sep 2026US 12,746,209 B2Generation Bio Co.
- Blood-brain barrier permeable heteroduplex nucleic acid29 Sep 2026US 12,746,253 B2National University Corporation Tokyo Medical and Dental University
- Lipids and compositions thereof15 Sep 2026US 12,734,249 B2Generation Bio Co.
- Hydrogel ink, hydrogel and uses thereof8 Oct 2026US 2026/0306528 A1
- Metabolic target for therapy of chronic vascular inflammation8 Oct 2026US 2026/0308588 A1Yale University
- Ionizable lipid compound, lipid carrier comprising same, and application1 Oct 2026US 2026/0294810 A1Innovec Biotherapeutics
- Aptamer-based sustained release of therapeutic agents1 Oct 2026US 2026/0294954 A1Children's Medical Center Corporation
- Cell1 Oct 2026US 2026/0297622 A1Antion Biosciences SA
Most cited
By later US patents
- Immunostimulatory nucleic acid molecules472US 6,207,646 B1Coley Pharmaceutical Group, Inc. · 2001
- Immunostimulatory nucleic acid molecules461US 6,239,116 B1Coley Pharmaceutical Group, Inc. · 2001
- Immunostimulatory nucleic acid molecules for activating dendritic cells265US 6,429,199 B1University of Iowa Research Foundation · 2002
- Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides190US 5,679,647 AThe Regents of the University of California · 1997
- Biodegradable poly(β-amino esters) and uses thereof153US 6,998,115 B2Massachusetts Institute of Technology · 2006